News & Press.
Learn the Latest Aziyo Updates
Aziyo Biologics Announces Launch of OsteGro® V
Expands Regenerative Medicine Product Portfolio and Leverages Proprietary Processing Platform to Protect and Preserve Native Bone Cells Silver Spring, Md. – June 29, 2020 – Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage, regenerative medicine...
Aziyo Biologics® Announces Exclusive Agreement with Medtronic® to Distribute FiberCel®
Silver Spring, Md. – June 20, 2019 – Aziyo Biologics, Inc., a fully integrated regenerative medicine company, announced today it has signed an exclusive, multi-year distribution agreement with Medtronic for the U.S. orthopedic market. Per the...
Aziyo Biologics and Boston Scientific Corporation Enter U.S. Sales Agent Agreement for CanGaroo® Envelope
Boston Scientific Sales Agents to Begin Selling Aziyo’s CanGaroo May 1st SILVER SPRING, MD. – May 1, 2019 – Aziyo Biologics, Inc., a fully integrated, commercially oriented regenerative medicine company, announced that it has entered into a U.S....
Aziyo Announces Publication of RECON Study of Pericardial Reconstruction Using ProxiCor
Prospective Study of 1,420 Patients Showed Statistically Significant Reduction in Post-Operative Complications and 30-Day Hospital Readmission Rates SILVER SPRING, MD. – April 9, 2019 – Aziyo®Biologics, Inc., a fully integrated regenerative...
Aziyo’s CanGaroo Envelope Cleared for Expanded Use with Neurostimulator Devices
SILVER SPRING, MD. – November 29, 2018 – Aziyo Biologics, Inc., a fully integrated regenerative medicine company, announced today that it has received U.S. Food and Drug Administration (FDA) clearance of the CanGaroo Envelope device for use with...